SRINIVAS AKKARAJU Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SRINIVAS AKKARAJU.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SRINIVAS AKKARAJU. SRINIVAS AKKARAJU is a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and a Director in aTYR PHARMA INC ($LIFE) and a Director in ADURO BIOTECH, INC. ($ADRO) and a Director in ZS Pharma, Inc. ($ZSPH) and a Director in Principia Biopharma Inc. ($PRNB) and a Director in Versartis, Inc. ($VSAR) and a Director in Syros Pharmaceuticals, Inc. ($SYRS) and a Director in Jiya Acquisition Corp. ($JYAC).

Companies in which SRINIVAS AKKARAJU is an Insider

Aravive, Inc.

Trading Symbol: ARAV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 576,066 shares
Current Value: $7,661,678
Latest Transaction: Dec 02 2019
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 15x
Sell: 0x
Shares Bought: 3,463,215
Shares Sold: 0
Share Difference: +3,463,215
Value Difference: -$19,255,982

aTYR PHARMA INC

Trading Symbol: LIFE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SRINIVAS AKKARAJU: Director
Holdings: 1,866,126 shares
Current Value: $6,344,828
Latest Transaction: May 11 2017
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CHINOOK THERAPEUTICS, INC.

Trading Symbol: ADRO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 3,168,388 shares
Current Value: $35,485,946
Latest Transaction: Jun 08 2021
$ADRO Market Capitalization: $745.72M
$ADRO Previous Close: $11.20

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 6,336,776
Shares Sold: 0
Share Difference: +6,336,776
Value Difference: $0

INTERCEPT PHARMACEUTICALS, INC.

Trading Symbol: ICPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 477,129 shares
Current Value: $54,187,541
Latest Transaction: Mar 12 2021
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 17x
Sell: 1x
Shares Bought: 676,705
Shares Sold: 23,438
Share Difference: +653,267
Value Difference: -$31,928,441

Jiya Acquisition Corp.

Trading Symbol: JYAC
Industry: BLANK CHECKS [6770]
Position of SRINIVAS AKKARAJU: Director
Holdings: 507,041 shares
Latest Transaction: Apr 15 2021

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 507,041
Shares Sold: 0
Share Difference: +507,041
Value Difference: -$5,070,410

Principia Biopharma Inc.

Trading Symbol: PRNB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 208,480 shares
Latest Transaction: Jan 10 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 383,480
Shares Sold: 0
Share Difference: +383,480
Value Difference: -$2,975,000

Seagen Inc.

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SRINIVAS AKKARAJU: Director
Holdings: 41,503 shares
Current Value: $2,522,967
Latest Transaction: May 19 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 10x
Sell: 3x
Shares Bought: 49,361
Shares Sold: 26,000
Share Difference: +23,361
Value Difference: +$2,972,570

Syros Pharmaceuticals, Inc.

Trading Symbol: SYRS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 1,899,616 shares
Current Value: $20,743,807
Latest Transaction: Dec 11 2020
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 9x
Shares Bought: 1,477,530
Shares Sold: 473,354
Share Difference: +1,004,176
Value Difference: -$1,417,050

ZS Pharma, Inc.

Trading Symbol: ZSPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 0 shares
Latest Transaction: Dec 21 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of SRINIVAS AKKARAJU

Sentiment: All, ARAV, LIFE, ADRO, ICPT, JYAC, PRNB, SGEN, SYRS, ZSPH

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 08 2021ADROCHINOOK THERAPEUTI ...AKKARAJU SRINIVASDirectorOption ExerciseA16.815,94899,9865,948
Apr 15 2021JYACJiya Acquisition C ...AKKARAJU SRINIVASDirectorOption ExerciseJ0.005,00002,412,447
Mar 12 2021ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP21.29147,0003,129,630640,688493.7 K to 640.7 K (+29.78 %)
Mar 12 2021ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP21.5516,559356,846493,688477.1 K to 493.7 K (+3.47 %)
Mar 12 2021ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP20.8373,4411,529,776477,129403.7 K to 477.1 K (+18.19 %)
Dec 11 2020SYRSSyros Pharmaceutic ...AKKARAJU SRINIVASDirectorOption ExerciseA11.00156,2501,718,750156,250
Dec 11 2020SYRSSyros Pharmaceutic ...AKKARAJU SRINIVASDirectorGrantA0.00625,00001,899,6161.3 M to 1.9 M (+49.03 %)

View all SRINIVAS AKKARAJU insider transactions.